Exercise Program for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a new exercise program, combining aerobic and resistance training, can improve health outcomes for people with heart failure with reduced ejection fraction (HFrEF) more effectively than the current standard exercise routine. Participants will be randomly assigned to one of two groups: one will try the new program (COMBO), and the other will continue with the traditional routine (PRIME). Suitable candidates have heart failure with specific characteristics, such as an ejection fraction under 45% and some limitations in daily activities.
As an unphased trial, this study provides participants the chance to contribute to innovative research that could enhance exercise strategies for heart failure.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this exercise program is safe for individuals with heart failure?
Research has shown that exercise programs like PRIME and COMBO are safe for people with heart failure. In a study of the COMBO program, heart failure patients completed over 60,000 hours of exercise without any exercise-related deaths, indicating the program is well-tolerated.
For PRIME, early studies suggest that older patients with chronic heart failure can manage the exercise routine. Although detailed information on side effects for PRIME remains limited, its testing in trials suggests reasonable safety. Both programs aim to improve health through supervised exercise, which is generally safe.12345Why are researchers excited about this trial?
Researchers are excited about the exercise programs COMBO and PRIME for heart failure because they offer a new approach to managing the condition. Unlike standard treatments that primarily focus on medications and lifestyle changes, these programs incorporate structured exercise regimens. The PRIME + COMBO approach starts with personalized training followed by progressive whole-body exercises, potentially offering enhanced cardiovascular benefits. Additionally, the COMBO-only program emphasizes continued progressive aerobic and resistance training, which might provide sustained improvements in heart function. These innovative exercise strategies could complement existing therapies and offer a more active way to improve heart health.
What evidence suggests that this trial's exercise programs could be effective for heart failure?
Research shows that exercise programs like the COMBO program, which participants in this trial may receive, can help people with heart failure by improving exercise capacity and enhancing quality of life. Studies have found that it can also improve heart function and reduce hospital visits. The PRIME program, another treatment option in this trial, focuses on a special type of exercise called peripheral remodeling. Early results suggest that PRIME might improve aerobic capacity, which is important for heart health. Both programs aim to support people with heart failure, but PRIME may offer unique benefits in how the body uses oxygen during exercise.16789
Who Is on the Research Team?
Jason Allen, PhD
Principal Investigator
University of Virginia
Are You a Good Fit for This Trial?
This trial is for individuals over 65 with heart failure and reduced ejection fraction (HFrEF), specifically those who can communicate well, have cardiologist approval, and a hemoglobin level of at least 10.0 g/dL. It's not for people with uncontrolled diabetes, recent heart attacks or embolism, severe valve disease needing surgery, new atrial fibrillation, worsening symptoms in the past few days, significant ischemia during low exercise levels, or certain other acute conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase 1: Treatment
Participants undergo 4 weeks of either PRIME or COMBO exercise training
Phase 2: Treatment
All participants undergo 8 weeks of progressive whole-body COMBO training
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- COMBO
- PRIME
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Virginia
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
National Institutes of Health (NIH)
Collaborator